Dog Immune-Mediated Polyarthritis and Welfare

Immune-mediated polyarthritis causes simultaneous inflammation in multiple joints, creating severe, acute pain that can be mistaken for other conditions and often responds dramatically to appropriate treatment.

Key Facts

IMPA causes neutrophilic inflammation in multiple joints simultaneously without infection
Dogs are acutely lame, reluctant to walk, and may resist joint manipulation due to severe pain
Type I IMPA is idiopathic while Types II-IV are associated with other diseases or drug reactions
Joint fluid cytology and culture are diagnostic - culture excludes septic arthritis
Glucocorticoid immunosuppression typically produces rapid, dramatic clinical improvement within days
Concurrent infectious disease workup is important as some infections trigger immune-mediated responses
Relapse rates require long, gradual immunosuppressive tapers over 4-6 months

Welfare Considerations

IMPA causes one of the more dramatic welfare transformations in clinical veterinary medicine: dogs that cannot rise without crying, that will not bear weight on any leg, and that appear profoundly unwell frequently recover to near-normal function within 48-72 hours of appropriate glucocorticoid treatment. The contrast makes the pre-treatment suffering all the more stark in retrospect. Recognition of IMPA as a differential for acute multi-limb lameness - rather than assuming orthopedic injury - allows prompt treatment that prevents extended unnecessary suffering.

What You Can Do

Seek emergency veterinary evaluation for dogs that are suddenly acutely lame in multiple legs
Request joint fluid analysis if your veterinarian suspects immune-mediated polyarthritis
Understand that rapid clinical improvement after steroids confirms but also diagnoses immune-mediated disease
Follow the complete immunosuppressive tapering protocol - premature cessation causes relapse and repeated suffering
Monitor for relapse signs including return of stiffness and reluctance to exercise during the taper